Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa. (Q38612845)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28832219%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

title

Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28832219%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28832219%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Andrew Duncan Steele

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28832219%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

2

Jacqueline E Tate

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28832219%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

5

Umesh D Parashar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28832219%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

3

Jason M Mwenda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28832219%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

language of work or name

1 reference

4 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28832219%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

28 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28832219%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28832219%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28832219%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

page(s)

987-995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28832219%20AND%20SRC:MED&resulttype=core&format=json

Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013.

28 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Norovirus and medically attended gastroenteritis in U.S. children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Predominance of norovirus and sapovirus in Nicaragua after implementation of universal rotavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Noroviruses: The Most Common Pediatric Viral Enteric Pathogen at a Large University Hospital After Introduction of Rotavirus Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Immunology of Gut Mucosal Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Assessment of environmental enteropathy in the MAL-ED cohort study: theoretical and analytic framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Performance of rotavirus vaccines in developed and developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Chronic bystander infections and immunity to unrelated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Environmental Enteropathy, Oral Vaccine Failure and Growth Faltering in Infants in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Rotavirus Serum IgA Immune Response in Children Receiving Rotarix Coadministered With bOPV or IPV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Incidence and clinical characteristics of group A rotavirus infections among children admitted to hospital in Kilifi, Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

High burden of rotavirus gastroenteritis in young children in rural western Kenya, 2010-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Anticipating rotavirus vaccines--a pre-vaccine assessment of incidence and economic burden of rotavirus hospitalizations among children < 5 year of age in Libya, 2012-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Diarrheal Disease in Rural Mozambique: Burden, Risk Factors and Etiology of Diarrheal Disease among Children Aged 0-59 Months Seeking Care at Health Facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Prospective hospital-based surveillance to estimate rotavirus disease burden in the Gauteng and North West Province of South Africa during 2003-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Profile: the KEMRI/CDC Health and Demographic Surveillance System--Western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Global burden of childhood pneumonia and diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Global causes of diarrheal disease mortality in children <5 years of age: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Global Illness and Deaths Caused by Rotavirus Disease in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Delayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine--a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Options for improving effectiveness of rotavirus vaccines in developing countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Rotavirus vaccines: current global impact and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Inequalities in full immunization coverage: trends in low- and middle-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Feasibility of using regional sentinel surveillance to monitor the rotavirus vaccine impact, effectiveness and intussusception incidence in the African Region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Preparing for the scale-up of rotavirus vaccine introduction in Africa: establishing surveillance platforms to monitor disease burden and vaccine impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Rotavirus vaccines in routine use

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Rotavirus vaccines: current status and future considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

A Randomized, Controlled Trial of the Impact of Alternative Dosing Schedules on the Immune Response to Human Rotavirus Vaccine in Rural Ghanaian Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Impact of different dosing schedules on the immunogenicity of the human rotavirus vaccine in infants in Pakistan: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

African rotavirus surveillance network: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1371595

Progress in the introduction of the rotavirus vaccine in Latin America and the Caribbean: four years of accumulated experience

21 January 2018

1 reference

12 December 2020

Review of Naturally Occurring Intussusception in Young Children in the WHO African Region prior to the Era of Rotavirus Vaccine Utilization in the Expanded Programme of Immunization

1 reference

12 December 2020

Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries

1 reference

12 December 2020

Progress in the introduction of rotavirus vaccine--Latin America and the Caribbean, 2006-2010.

1 reference

12 December 2020

Racecadotril for the treatment of severe acute watery diarrhoea in children admitted to a tertiary hospital in Kenya

1 reference

12 December 2020

Monovalent Rotavirus Vaccine Effectiveness and Impact on Rotavirus Hospitalizations in Zanzibar, Tanzania: Data From the First 3 Years After Introduction

1 reference

12 December 2020

Rotavirus vaccines:an update

1 reference

12 December 2020

Racecadotril in the Management of Rotavirus and Non-rotavirus Diarrhea in Under-five Children: Two Randomized, Double-blind, Placebo-controlled Trials.

1 reference

12 December 2020

10.1080/14760584.2017.1371595

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28832219%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28832219%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

PubMed publication ID

28832219

1 reference